Cite Filings / AARD / 0001415889-25-005246

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Aardvark Therapeutics, Inc. Filed 2025-02-24 Acc 0001415889-25-005246

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-05-15 SCHEDULE 13G Statement of Beneficial Ownership
2025-02-24 SCHEDULE 13G Statement of Beneficial Ownership
2025-02-24 SCHEDULE 13G Statement of Beneficial Ownership
2025-02-24 SCHEDULE 13G Statement of Beneficial Ownership
2025-02-19 4 10% owner bought 1,250,000 shares at $16.00 ($20,000,000)
2025-02-19 4 Director acquired 133,364 shares (conversion)
2025-02-19 4 10% owner acquired 2,050,902 shares (conversion)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…